GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » Change In Other Working Capital

Ryvu Therapeutics (WAR:RVU) Change In Other Working Capital : zł-14.99 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics Change In Other Working Capital?

Ryvu Therapeutics's Change In Other Working Capital for the quarter that ended in Dec. 2024 was zł10.11 Mil. It means Ryvu Therapeutics's Other Working Capital increased by zł10.11 Mil from Sep. 2024 to Dec. 2024 .

Ryvu Therapeutics's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was zł-14.41 Mil. It means Ryvu Therapeutics's Other Working Capital declined by zł14.41 Mil from Dec. 2023 to Dec. 2024 .

Ryvu Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Ryvu Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ryvu Therapeutics Change In Other Working Capital Chart

Ryvu Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.00 -10.75 71.59 10.30 -14.41

Ryvu Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.40 -14.57 -4.54 -6.00 10.11

Ryvu Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-14.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryvu Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ryvu Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » Change In Other Working Capital
Comparable Companies
WAR:BCX WAR:BIO WAR:SVE WAR:MAB WAR:MOC WAR:PTG WAR:CTX WAR:URT WAR:NNG WAR:RDG VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
9Y4:Germany
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Website
https://www.ryvu.com
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics Headlines

No Headlines